CHCT on NYSE
Community Healthcare Trust Inc
In its 2026 annual report the company says: “We are a fully-integrated healthcare real estate company organized as a corporation in the State of Maryland on March 28, 2014. We own and acquire real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers.”5 It is headquartered in Franklin, United States.2 Its shares trade on NYSE under the symbol CHCT.2
Price unavailable
Last updated Oct 20, 2026.
Overview
Compare with Net Lease Office Properties, Extra Space Storage or FRANKLIN STREET PROPERTIES CORP /MA/, or pick any stock.
- TickerCHCT on NYSE2
- IndustryReal Estate Investment Trusts2
- HeadquartersFranklin, United States2
- Incorporated inMD3
- Business address3326 Aspen Grove Drive, Suite 150, Franklin, Tn 370673
- Filer categoryAccelerated filer3
- Legal formStock Corporation2
- LEI549300FATSRCMKOV95362
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O CSC-LAWYERS INCORPORATING SERVICE COMPANY, 21202 Baltimore, United States2
- Registered withBusiness Services (Maryland Department of Assessments and Taxation), D157786322
See how the biggest companies compare on our leaderboards
We are a fully-integrated healthcare real estate company organized as a corporation in the State of Maryland on March 28, 2014. We own and acquire real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs96¢$115.9M
- Income tax0¢$177.0K
- Profit4¢$5.1M
Out of $121.2M in revenue.6
Where each dollar of operating cash went, fiscal 2025
- Dividends paid95¢$53.7M
- Kept or used elsewhere5¢$2.8M
Out of $56.4M of cash from operations.6
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Rental income | $121.4M | $114.6M | $108.7M |
| Other operating interest | -$156.0K | $1.2M | $4.2M |
| Total revenue | $121.2M | $115.8M | $112.8M |
| Property operating | $23.6M | $22.8M | $20.7M |
| General and administrative | $25.1M | $19.1M | $27.3M |
| Depreciation and amortization | $43.5M | $42.8M | $39.7M |
| Total expenses | $92.3M | $84.7M | $87.7M |
| Gains on the sales of depreciable real estate assets, net of losses and impairments | $11.8M | -$121.0K | -$102.0K |
| Interest expense | -$27.0M | -$23.7M | -$17.8M |
| Credit loss reserve | -$8.7M | -$11.0M | $0 |
| Deferred income tax expense | -$23.0K | $0 | -$306.0K |
| Interest and other income, net | $34.0K | $530.0K | $813.0K |
| Total | -$23.8M | -$34.3M | -$17.4M |
| NET INCOME (LOSS) | $5.1M | -$3.2M | $7.7M |
| Net (loss) income per common share - Basic (in dollars per share) | $0.08 | -$0.23 | $0.20 |
| Net (loss) income per common share - Diluted (in dollars per share) | $0.08 | -$0.23 | $0.20 |
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC (in shares) | 26.9M shares | 26.5M shares | 25.2M shares |
| WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED (in shares) | 26.9M shares | 26.5M shares | 25.2M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Land and land improvements | $154.7M | $149.5M | ||
| Buildings, improvements, and lease intangibles | $1.0B | $996.1M | ||
| Personal property | $813.0K | $326.0K | ||
| Total real estate properties | $1.2B | $1.1B | ||
| Less accumulated depreciation | -$280.3M | -$242.6M | ||
| Total real estate properties, net | $922.9M | $903.3M | ||
| Cash and cash equivalents | $3.3M | $4.4M | ||
| Assets held for sale | $5.3M | $6.8M | ||
| Other assets, net | $59.2M | $78.1M | ||
| Total assets | $990.8M | $992.6M | ||
| Debt, net | $532.2M | $486.0M | ||
| Accounts payable and accrued liabilities | $14.9M | $14.3M | ||
| Other liabilities, net | $14.2M | $16.4M | ||
| Total liabilities | $561.4M | $516.6M | ||
| Preferred stock, $0.01 par value; 50,000 shares authorized; none issued and outstanding | $0 | $0 | ||
| Common stock, $0.01 par value; 450,000 shares authorized; 28,471 and 28,242 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $285.0K | $282.0K | ||
| Additional paid-in capital | $717.5M | $704.5M | ||
| Cumulative net income | $90.8M | $85.7M | ||
| Accumulated other comprehensive income | $6.7M | $17.6M | ||
| Cumulative dividends | -$385.8M | -$332.1M | ||
| Total stockholders equity | $429.4M | $476.0M | ||
| Total liabilities and stockholders' equity | $990.8M | $992.6M | ||
| Preferred Stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Preferred Stock, shares authorized (in shares) | 50.0M shares | 50.0M shares | ||
| Preferred Stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred Stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common Stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Common Stock, shares authorized (in shares) | 450.0M shares | 450.0M shares | ||
| Common Stock, shares issued (in shares) | 28.5M shares | 28.2M shares | ||
| Common Stock, shares outstanding (in shares) | 28.5M shares | 28.2M shares | 27.6M shares | 25.9M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Land and land improvements | $154.7M | $149.5M | ||
| Buildings, improvements, and lease intangibles | $1.0B | $996.1M | ||
| Personal property | $813.0K | $326.0K | ||
| Total real estate properties | $1.2B | $1.1B | ||
| Less accumulated depreciation | -$280.3M | -$242.6M | ||
| Total real estate properties, net | $922.9M | $903.3M | ||
| Cash and cash equivalents | $3.3M | $4.4M | ||
| Assets held for sale | $5.3M | $6.8M | ||
| Other assets, net | $59.2M | $78.1M | ||
| Total assets | $990.8M | $992.6M | ||
| Debt, net | $532.2M | $486.0M | ||
| Accounts payable and accrued liabilities | $14.9M | $14.3M | ||
| Other liabilities, net | $14.2M | $16.4M | ||
| Total liabilities | $561.4M | $516.6M | ||
| Preferred stock, $0.01 par value; 50,000 shares authorized; none issued and outstanding | $0 | $0 | ||
| Common stock, $0.01 par value; 450,000 shares authorized; 28,471 and 28,242 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $285.0K | $282.0K | ||
| Additional paid-in capital | $717.5M | $704.5M | ||
| Cumulative net income | $90.8M | $85.7M | ||
| Accumulated other comprehensive income | $6.7M | $17.6M | ||
| Cumulative dividends | -$385.8M | -$332.1M | ||
| Total stockholders equity | $429.4M | $476.0M | ||
| Total liabilities and stockholders' equity | $990.8M | $992.6M | ||
| Preferred Stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Preferred Stock, shares authorized (in shares) | 50.0M shares | 50.0M shares | ||
| Preferred Stock, shares issued (in shares) | 0 shares | 0 shares | ||
| Preferred Stock, shares outstanding (in shares) | 0 shares | 0 shares | ||
| Common Stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Common Stock, shares authorized (in shares) | 450.0M shares | 450.0M shares | ||
| Common Stock, shares issued (in shares) | 28.5M shares | 28.2M shares | ||
| Common Stock, shares outstanding (in shares) | 28.5M shares | 28.2M shares | 27.6M shares | 25.9M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income (loss) | $5.1M | -$3.2M | $7.7M |
| Depreciation and amortization | $43.5M | $42.8M | $39.7M |
| Other amortization | $1.3M | $927.0K | $746.0K |
| Stock-based compensation | $10.3M | $10.0M | $8.2M |
| Accelerated amortization of stock-based compensation | $4.6M | $0 | $11.8M |
| Straight-line rent receivables | -$3.7M | -$1.9M | -$3.1M |
| (Gains) on the sales of depreciable real estate assets, net of losses and impairments | -$11.8M | $121.0K | $102.0K |
| Credit loss reserve | $8.7M | $11.0M | $0 |
| Net gain from insurance recovery on casualty loss | $0 | $0 | -$706.0K |
| Deferred income tax expense | $23.0K | $0 | $306.0K |
| Other assets | $994.0K | -$3.3M | -$3.0M |
| Accounts payable and accrued liabilities | -$1.2M | $2.3M | $859.0K |
| Other liabilities | -$1.4M | $221.0K | -$1.3M |
| Net cash provided by operating activities | $56.4M | $58.9M | $61.4M |
| Acquisitions of real estate | -$64.6M | -$72.4M | -$98.9M |
| Proceeds from the sale of real estate | $32.2M | $2.3M | $0 |
| Funding of notes receivable | $0 | -$3.1M | -$2.0M |
| Proceeds from repayments on notes receivable | $5.2M | $5.1M | $3.9M |
| Insurance proceeds from casualty loss | $0 | $0 | $2.3M |
| Capital expenditures on existing real estate properties | -$20.5M | -$24.6M | -$19.0M |
| Net cash used in investing activities | -$47.7M | -$92.7M | -$113.7M |
| Net borrowings on revolving credit facility | $46.0M | $162.0M | $50.0M |
| Term loan repayments | $0 | -$75.0M | $0 |
| Mortgage note repayments | $0 | -$4.8M | -$126.0K |
| Dividends paid | -$53.7M | -$51.7M | -$48.1M |
| Proceeds from issuance of common stock | $0 | $7.5M | $44.2M |
| Taxes paid on behalf of employees and shares withheld upon shares vesting | -$1.8M | -$785.0K | -$963.0K |
| Equity issuance costs | -$317.0K | -$223.0K | -$227.0K |
| Debt issuance costs | $0 | -$3.4M | $0 |
| Net cash (used in) provided by financing activities | -$9.8M | $33.5M | $44.9M |
| Decrease in cash, cash equivalents and restricted cash | -$1.0M | -$249.0K | -$7.4M |
| Interest paid | $25.9M | $23.1M | $17.1M |
| Invoices accrued for construction, tenant improvement and other capitalized costs | $6.6M | $4.6M | $3.9M |
| Reclassification of registration statement costs to equity issuance costs | $175.0K | $354.0K | $197.0K |
| (Decrease) increase in fair value of cash flow hedges | -$3.9M | $11.6M | $3.8M |
| Capitalized interest | $210.0K | $216.0K | $611.0K |
No quarter-by-quarter statement was filed.
Corporate structure
Community Healthcare Trust Inc sits at the top of its group. 44 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Community Healthcare Trust Inc
- Global X Management CO LLC Filed SCHEDULE 13G on Community Healthcare Trust Inc, latest May 15, 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC Filed SCHEDULE 13G on Community Healthcare Trust Inc, latest Apr 29, 2026
- VANGUARD GROUP INC Filed SCHEDULE 13G/A on Community Healthcare Trust Inc, latest Mar 26, 2026 (4 filings since Feb 9, 2022)
- BlackRock Filed SCHEDULE 13G/A on Community Healthcare Trust Inc, latest Jan 21, 2026 (3 filings since Oct 7, 2024)
- State Street Corporation Filed SC 13G/A on Community Healthcare Trust Inc, latest Oct 17, 2024 (4 filings since Feb 10, 2022)
- Community Healthcare Trust Inc Franklin, Tennessee, United States
- CHCT Alabama, LLC Subsidiary · Delaware, United States
- CHCT Arizona, LLC Subsidiary · Delaware, United States
- CHCT Arkansas, LLC Subsidiary · Delaware, United States
- CHCT California, LLC Subsidiary · Delaware, United States
- CHCT Colorado, LLC Subsidiary · Delaware, United States
- CHCT Connecticut II, LLC Subsidiary · Delaware, United States
- CHCT Connecticut, LLC Subsidiary · Delaware, United States
- CHCT Florida, LLC Subsidiary · Delaware, United States
- CHCT Georgia, LLC Subsidiary · Delaware, United States
- CHCT Holdings, Inc. Subsidiary · Delaware, United States
- CHCT Idaho, LLC Subsidiary · Delaware, United States
- CHCT Illinois, LLC Subsidiary · Delaware, United States
- CHCT Indiana, LLC Subsidiary · Delaware, United States
- CHCT Iowa, LLC Subsidiary · Delaware, United States
- CHCT Kansas, LLC Subsidiary · Delaware, United States
- CHCT Kentucky, LLC Subsidiary · Delaware, United States
- CHCT Lending, LLC Subsidiary · Delaware, United States
- CHCT Louisiana, LLC Subsidiary · Delaware, United States
- CHCT Maryland, LLC Subsidiary · Delaware, United States
- CHCT Massachusetts, LLC Subsidiary · Delaware, United States
- CHCT Michigan, LLC Subsidiary · Delaware, United States
- CHCT Minnesota, LLC Subsidiary · Delaware, United States
- CHCT Mississippi, LLC Subsidiary · Delaware, United States
- CHCT Missouri, LLC Subsidiary · Delaware, United States
- CHCT Nebraska, LLC Subsidiary · Delaware, United States
- and 18 more
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Community Healthcare Trust Inc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Land and buildings | $154.7M6 Dec 31, 2025 | $149.5M6 Dec 31, 2024 | +3.5% |
| Finance-lease assets | $2.4M6 Dec 31, 2025 | $2.4M6 Dec 31, 2024 | −2.4% |
| Operating-lease assets (leased space) | $667.0K6 Dec 31, 2025 | $698.0K6 Dec 31, 2024 | −4.4% |
Real estate and locations
| Item | Latest | A year before | Change |
|---|---|---|---|
| Real estate investments, net | $922.9M6 Dec 31, 2025 | $903.3M6 Dec 31, 2024 | +2.2% |
| Real estate investments, at cost | $1.2B6 Dec 31, 2025 | $1.2B10 Dec 31, 2024 | +5.3% |
| Real estate accumulated depreciation | $280.3M6 Dec 31, 2025 | $242.6M6 Dec 31, 2024 | +15.5% |
| Real estate properties | 1986 Dec 31, 2025 | 20010 Dec 31, 2024 | −1.0% |
| Area of real estate | 4.5 million sq ft6 Dec 31, 2025 | 4.4 million sq ft10 Dec 31, 2024 | +2.3% |
Investments
Properties, in its own words
In addition to the information provided below, see Item 1, "Business," Note 2 – Real Estate Investments to the Consolidated Financial Statements in Item 8 "Financial Statements and Supplementary Data," and Schedule III of Item 15 of this Annual Report on Form 10-K for more detailed information about the Company's properties as of December 31, 2025.
Scheduled Lease Expirations
The rest of Item 2
As of December 31, 2025, the weighted average remaining years to maturity pursuant to the leases with our tenants was approximately 7.0 years, with expirations through 2046. The table below details scheduled lease expirations, as of December 31, 2025, for our properties for the periods indicated.
Total Leased Square Footage · Annualized Lease Revenue
Year · Number of Leases Expiring · Amount (in thousands) · Percent (%) · Amount (in thousands) · Percent (%)
2026 · 77 · 460 · 11.3 · 10,144 · 9.0
2027 · 68 · 373 · 9.2 · 8,099 · 7.2
2028 · 70 · 480 · 11.8 · 10,070 · 8.9
2029 · 45 · 370 · 9.1 · 9,454 · 8.4
2030 · 37 · 303 · 7.4 · 6,918 · 6.1
2031 · 28 · 390 · 9.6 · 10,884 · 9.6
2032 · 25 · 206 · 5.1 · 4,070 · 3.6
2033 · 13 · 75 · 1.8 · 1,655 · 1.5
2034 · 19 · 255 · 6.3 · 9,356 · 8.3
2035 · 16 · 233 · 5.7 · 8,831 · 7.8
Thereafter · 32 · 890 · 21.7 · 32,080 · 28.5
Month-to-Month · 9 · 41 · 1.0 · 1,230 · 1.1
Totals · 439 · 4,076 · 100.0 · 112,791 · 100.0
Item 2 of the 10-K filed Feb 17, 2026.5
Leadership
Who has led Community Healthcare Trust Inc, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerDavid H. Dupuy Apr 21, 2023 to now14
- Chief executive officerTimothy G. Wallace May 20, 2015 to Jan 13, 202315
- ChairTimothy G. Wallace May 20, 2015 to Jan 13, 202315
- PresidentDavid H. Dupuy Jul 28, 2023 to now16
- PresidentTimothy G. Wallace May 20, 2015 to Jan 13, 202315
- Chief financial officerWilliam G. Monroe Iv. Jun 1, 2023 to now17
- Chief financial officerDavid H. Dupuy May 1, 2019 to Apr 21, 202318
- Chief financial officerW. Page Barnes May 20, 2015 to Jan 15, 201919
- Chief operating officerW. Page Barnes Aug 19, 2019 to Aug 17, 202020
Board members and other officers (7)
- VP Financial Reporting & CAOLeigh Ann Stach May 20, 2015 to now21
- Board memberDavid H. Dupuy Apr 21, 2023 to now14
- Board memberCathrine Cotman May 9, 2022 to now22
- Board memberClaire M. Gulmi May 21, 2018 to now23
- Board memberAlan Gardner May 20, 2015 to now24
- Board memberAlfred Lumsdaine May 22, 2015 to Jun 20, 201725
- Board memberRobert Z. Hensley May 22, 2015 to now26
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- CHCT Alabama, LLC Delaware4
- CHCT Arizona, LLC Delaware4
- CHCT Arkansas, LLC Delaware4
- CHCT California, LLC Delaware4
- CHCT Colorado, LLC Delaware4
- CHCT Connecticut II, LLC Delaware4
- CHCT Connecticut, LLC Delaware4
- CHCT Florida, LLC Delaware4
- CHCT Georgia, LLC Delaware4
- CHCT Holdings, Inc. Delaware4
- CHCT Idaho, LLC Delaware4
- CHCT Illinois, LLC Delaware4
- CHCT Indiana, LLC Delaware4
- CHCT Iowa, LLC Delaware4
- CHCT Kansas, LLC Delaware4
- CHCT Kentucky, LLC Delaware4
- CHCT Lending, LLC Delaware4
- CHCT Louisiana, LLC Delaware4
- CHCT Maryland, LLC Delaware4
- CHCT Massachusetts, LLC Delaware4
- CHCT Michigan, LLC Delaware4
- CHCT Minnesota, LLC Delaware4
- CHCT Mississippi, LLC Delaware4
- CHCT Missouri, LLC Delaware4
All 44 listed subsidiaries
- CHCT Nebraska, LLC Delaware4
- CHCT Nevada, LLC Delaware4
- CHCT New Hampshire, LLC Delaware4
- CHCT New Jersey, LLC Delaware4
- CHCT New York, LLC Delaware4
- CHCT North Carolina, LLC Delaware4
- CHCT Ohio, LLC Delaware4
- CHCT Oklahoma, LLC Delaware4
- CHCT Pennsylvania, LLC Delaware4
- CHCT Rhode Island, LLC Delaware4
- CHCT South Carolina, LLC Delaware4
- CHCT Tennessee, LLC Delaware4
- CHCT Texas, LLC Delaware4
- CHCT Virginia, LLC Delaware4
- CHCT Washington, LLC Delaware4
- CHCT West Virginia, LLC Delaware4
- CHCT Wisconsin, LLC Delaware4
- Community Healthcare OP, LP Delaware4
- Community Healthcare Trust Services, Inc. Tennessee4
- Community Healthcare Trust, LLC Delaware4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Aug 4, 20268-K Results of operations; Regulation FD disclosure27
- May 7, 20268-K Shareholder vote28
- May 5, 20268-K Results of operations; Regulation FD disclosure29
- Feb 17, 20268-K Results of operations; Regulation FD disclosure30
- Jan 9, 20268-K Executive or director change31
- Oct 29, 20258-K Regulation FD disclosure32
- Oct 28, 20258-K Results of operations; Regulation FD disclosure33
- Jul 29, 20258-K Results of operations; Regulation FD disclosure34
- May 6, 20258-K Executive or director change; Other events35
- May 1, 20258-K Shareholder vote36
- Apr 29, 20258-K Results of operations; Regulation FD disclosure37
- Feb 18, 20258-K Entered a material agreement; Other events38
- Apr 21, 2023New chief executive David H. Dupuy becomes CEO14
- May 20, 2015New chief executive Timothy G. Wallace becomes CEO15
- Mar 28, 2014Founded Community Healthcare Trust Inc is founded2
Calendar
Coming up
- Nov 3, 2026 · After the closeReports results for the quarter ending Sep/2026 A year earlier it reported $0.56 a share, on Oct 28, 2025.39
When it reported results
- Aug 4, 2026Reported quarterly or annual results27
- May 5, 2026Reported quarterly or annual results29
- Feb 17, 2026Reported quarterly or annual results30
- Oct 28, 2025Reported quarterly or annual results33
- Jul 29, 2025Reported quarterly or annual results34
- Apr 29, 2025Reported quarterly or annual results37
- Feb 18, 2025Reported quarterly or annual results40
- Oct 29, 2024Reported quarterly or annual results41
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
263 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 45 major events, 149 insider forms, 18 large holders, 31 other. The latest 20:
- Aug 18, 20264 EDGAR
- Aug 18, 20264 EDGAR
- Aug 18, 20264 EDGAR
- Aug 17, 20264 EDGAR
- Aug 12, 20264 EDGAR
- Aug 4, 20268-K EDGAR
- Aug 4, 202610-Q EDGAR
- Aug 3, 20264 EDGAR
- Aug 3, 20264 EDGAR
- Aug 3, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- May 26, 20264 EDGAR
- May 26, 20264 EDGAR
- May 26, 20264 EDGAR
- May 26, 20264 EDGAR
- May 26, 20264 EDGAR
- May 15, 2026SCHEDULE 13G EDGAR
- May 8, 20264 EDGAR
The 263 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
16 open-market trades by officers, directors and large owners since October 2021: 15 buys and 1 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Dupuy David H.CEO and President | Buy | 10,000 | $15.13 | $151.3K | Form 4 |
| Aug 11, 2026 | Hensley Robert ZDirector | Buy | 8,000 | $15.21 | $121.7K | Form 4 |
| Nov 4, 2025 | Cotman CathrineDirector | Buy | 4,000 | $14.66 | $58.6K | Form 4 |
| May 28, 2025 | Van Horn R. LawrenceDirector | Buy | 11,815 | $16.37 | $193.4K | Form 4 |
| May 13, 2025 | Dupuy David H.CEO and President | Buy | 10,000 | $16.23 | $162.3K | Form 4 |
| Apr 30, 2025 | Cotman CathrineDirector | Buy | 3,000 | $17.10 | $51.3K | Form 4 |
| Apr 30, 2025 | Cotman CathrineDirector | Sale | 3,000 | $17.09 | $51.3K | Form 4 |
| Sep 9, 2024 | Van Horn R. LawrenceDirector | Buy | 10,000 | $16.13 | $161.3K | Form 4 |
| Aug 13, 2024 | Cotman CathrineDirector | Buy | 2,000 | $17.72 | $35.4K | Form 4 |
| Aug 5, 2024 | Hensley Robert ZDirector | Buy | 6,500 | $19.50 | $126.8K | Form 4 |
| Aug 5, 2024 | Van Horn R. LawrenceDirector | Buy | 2,500 | $19.42 | $48.5K | Form 4 |
| Aug 5, 2024 | Dupuy David H.CEO and President | Buy | 10,000 | $19.48 | $194.8K | Form 4 |
| Mar 10, 2023 | Cotman CathrineDirector | Buy | 277 | $36.24 | $10.0K | Form 4 |
| Mar 10, 2023 | Van Horn R. LawrenceDirector | Buy | 685 | $36.43 | $25.0K | Form 4 |
| Mar 9, 2023 | GULMI CLAIRE MDirector | Buy | 2,042 | $36.77 | $75.1K | Form 4 |
| Mar 9, 2023 | Gardner AlanDirector | Buy | 2,700 | $36.74 | $99.2K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Global X Management CO LLCSCHEDULE 13G, 1 filing May 15, 202642
- VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202643
- VANGUARD GROUP INCSCHEDULE 13G/A, 4 filings Feb 9, 2022 to Mar 26, 202644
- BlackRockSCHEDULE 13G/A, 3 filings Oct 7, 2024 to Jan 21, 202645
- State Street CorporationSC 13G/A, 4 filings Feb 10, 2022 to Oct 17, 202446
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Timothy L. MeyerFormer Executive Vice President - Asset Management, through May 31, 2025 | $5.1M47 | ||
| 2025 | David H. DupuyChief Executive Officer and President | $2.4M47 | ||
| 2025 | William G. MonroeChief Financial Officer and Executive Vice President | $2.1M47 | ||
| 2025 | Leigh Ann StachChief Accounting Officer and Executive Vice President | $1.5M47 | ||
| 2024 | David H. DupuyChief Executive Officer and President | $3.1M47 | ||
| 2024 | William G. MonroeChief Financial Officer and Executive Vice President | $2.4M47 | ||
| 2024 | Leigh Ann StachChief Accounting Officer and Executive Vice President | $1.9M47 | ||
| 2024 | Timothy L. MeyerFormer Executive Vice President - Asset Management, through May 31, 2025 | $1.5M47 | ||
| 2023 | David H. DupuyChief Executive Officer and President | $3.5M47 | ||
| 2023 | Leigh Ann StachChief Accounting Officer and Executive Vice President | $2.5M47 | ||
| 2023 | Timothy L. MeyerFormer Executive Vice President - Asset Management, through May 31, 2025 | $1.9M47 | ||
| 2023 | William G. MonroeChief Financial Officer and Executive Vice President | $1.4M47 |
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How Community Healthcare Trust Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARCommunity Healthcare Trust Inc1
- CIK0001631569
- Employer ID (EIN)46-52120335
- Filer statusAccelerated filer not an emerging growth company; not a smaller reporting company; not a shell company5
- Incorporated inMaryland5
- Fiscal year endsDecember 311
- Industry code (SIC)6798 Real Estate Investment Trusts1
- SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
- Business address3326 Aspen Grove Drive, Suite 150, Franklin, TN 370671
- Phone615-771-30521
- Shares outstanding28,653,842 as of Jul 28, 202612
- Public float$448.8M as of Jun 30, 20255
- AuditorBDO USA, P.C., Nashville, Tennessee PCAOB ID 243; it also attests to the company’s internal control over financial reporting5
- On EDGAR sinceFeb 17, 20151
- Filings618 in all: 4 (283), 8-K (112), 10-Q (34), SC 13G/A (32), DEFA14A (18), SC 13G (15), S-8 (13), 3 (12)1
All 35 form types
10-K (11), DEF 14A (11), 4/A (10), CORRESP (9), UPLOAD (8), 424B5 (6), 5 (6), EFFECT (5), ARS (4), S-11/A (4), SCHEDULE 13G/A (3), 424B4 (2), DRSLTR (2), S-11 (2), S-3 (2), S-3ASR (2), SCHEDULE 13G (2), 10-Q/A (1), 3/A (1), 424B8 (1), 8-A12B (1), 8-K/A (1), CERTNYS (1), DRS (1), DRS/A (1), POS AM (1), POSASR (1)
- Latest filingsAnnual report (10-K) Feb 17, 2026
Quarterly report (10-Q) Aug 4, 2026
Proxy statement (DEF 14A) Mar 12, 2026
Latest 8-K (8-K) Aug 4, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common stock, $0.01 par value per share | CHCT | New York Stock Exchange |
From the cover page of the 10-K filed Feb 17, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks Community Healthcare Trust Inc names in Item 1A of its 10-K filed Feb 17, 2026: 75 risks under these headings, as written.5
- Risks Related to Our Business
- Our real estate investments are concentrated in healthcare properties, making us more vulnerable economically than if our investments were diversified in other segments of the economy.
- Given our dependence on rental revenue, failure by our major tenants to make rental payments to us, because of a deterioration of their financial condition, a termination of their leases, a non-renewal of their leases or otherwise, could have a material adverse effect on our results of operations.
- We may be unable to source off-market or lightly marketed deal flow in the future, which may have a material adverse effect on our growth.
- Inflation and the U.S. government’s response thereto could adversely impact our tenants and our operations.
- Changes to U.S. tariff and import/export regulations may have an adverse effect on our business, financial condition and results of operations.
- We depend on the continued services and performance of our senior management and other key employees, the loss of any of whom could adversely affect our business, operating results, financial condition, and stock price.
- We may be unable to complete any pending acquisitions, which would adversely affect our ability to make distributions to our stockholders and could have a material adverse impact on our results of operations, earnings and cash flow, and even if acquisitions are completed, we may fail to successfully operate acquired properties.
- We may obtain only limited warranties when we purchase a property, which, in turn, would only provide us with limited recourse against the seller if issues arise after our purchase of a property.
- We may be unable to successfully acquire properties and expand our operations into new or existing target submarkets.
- A pandemic, epidemic, outbreak of a contagious disease, or other health crisis may adversely affect our tenants' financial condition and the profitability of our properties.
- The bankruptcy, insolvency or weakened financial position of our tenants, and particularly our largest tenants, could materially and adversely affect our operating results and financial condition.
The other 64 risks
- We may have difficulty finding suitable replacement tenants in the event of non-renewal of our leases or a tenant default.
- We may be unable to secure funds for future tenant or other capital improvements or payment of leasing commissions, which could limit our ability to attract or replace tenants and adversely impact our ability to make cash distributions to our stockholders.
- We may be required to make rent or other concessions and significant capital expenditures to improve our properties in order to retain and attract tenants, which could adversely affect our financial condition, results of operations and cash flow.
- Supply chain disruptions and unexpected construction expenses and delays could impact our ability to timely deliver spaces to tenants and/or our ability to achieve the expected value of a construction project or lease, thereby adversely affecting our profitability.
- Some of the leases at our properties contain “early termination” provisions which, if triggered, may allow tenants to terminate their leases without further payment to us, which could adversely affect our financial condition and results of operations and the value of the applicable property.
- Adverse economic or other conditions in the geographic markets in which we conduct business could negatively affect our occupancy levels and rental rates and have a material adverse effect on our operating results.
- Climate change may adversely affect our business.
- Environmental, social and governance matters may cause us to incur additional costs, make personnel changes, and affect the attractiveness of our stock to investors.
- A large percentage of our annualized rent is provided by properties that are located in Texas and Florida and changes in these markets may materially adversely impact our business and financial condition.
- We will rely upon external sources of capital to fund future capital needs, and, if we encounter difficulty in obtaining such capital, we may not be able to make future acquisitions necessary to grow our business or meet maturing obligations.
- Covenants related to our indebtedness could limit our operations.
- We may not be able to control our expenses or our expenses may remain constant or increase, even if our revenue does not increase, which could cause our results of operations to be adversely affected.
- Our ability to issue equity to expand our business will depend, in part, upon the market price of our common stock, and our failure to meet market expectations with respect to our business could adversely affect the market price of our common stock and thereby limit our ability to raise capital.
- We have now, and may have in the future, exposure to contingent rent escalators, which can hinder our growth and profitability.
- Our investments in development projects may not yield anticipated returns which could directly affect our operating results and reduce the amount of funds available for distributions.
- Notes receivable in which we may invest in may be impacted by unfavorable real estate market conditions, which could decrease their value.
- Delays in liquidating defaulted note investments could reduce our investment returns.
- We rely on information technology in our operations, and any material failure, inadequacy, interruption or security failure of that technology could harm our business.
- Cybersecurity incidents could disrupt our business and result in the unavailability or compromise of confidential information.
- Risks Related to the Healthcare Industry
- The healthcare industry is heavily regulated and new laws or regulations, changes to existing laws or regulations, changes to reimbursement models or structure, loss of licensure or failure to obtain licensure could adversely impact our company and result in the inability of our tenants to make rent payments to us.
- Adverse trends in healthcare provider operations may negatively affect our lease revenues and our ability to make distributions to our stockholders.
- Reductions in reimbursement from third-party payers, including Medicare and Medicaid, could adversely affect the profitability of our tenants and hinder their ability to make rent payments to us or renew their lease.
- Our tenants and our Company are subject to fraud and abuse laws, the violation of which by a tenant may jeopardize the tenant’s ability to make rent payments to us.
- Our tenants may be subject to compliance issues and cyber-attacks associated with the protection of personal information.
- Our healthcare-related tenants may be subject to significant legal actions that could subject them to increased operating costs and substantial uninsured liabilities, which may affect their ability to pay their rent payments to us, and we could be subject to healthcare industry violations.
- Risks Related to the Real Estate Industry
- Illiquidity of real estate investments could significantly impede our ability to respond to adverse changes in the performance of our properties.
- We may suffer reduced or delayed revenues for, or have difficulty selling, properties with vacancies.
- Uncertain market conditions could cause us to sell our healthcare properties at a loss in the future.
- If we sell properties by providing financing to purchasers, defaults by the purchasers would adversely affect our cash flows.
- Uninsured losses relating to real property may adversely affect your returns.
- Rising expenses could reduce cash flow and funds available for future acquisitions.
- Our property taxes could increase due to property tax rate changes or reassessments, which could materially adversely impact our cash flows.
- Our properties may contain or develop harmful mold or suffer from other air quality issues, which could lead to liability for adverse health effects and costs of remediation.
- We may incur significant costs complying with various federal, state and local laws, regulations and covenants that are applicable to our properties.
- Environmental compliance costs and liabilities associated with owning and leasing our properties may affect our results of operations.
- Some of the properties we acquire may be subject to ground lease or other restrictions on the use of the space. If we are required to undertake significant capital expenditures to procure new tenants, then our business and results of operations may suffer.
- Our assets may be subject to impairment charges.
- Risks Related to our Corporate Structure and the Acquisition of Properties
- Conflicts of interest could arise in the future between the interests of our stockholders and the interests of holders of OP units, which may impede business decisions that could benefit our stockholders.
- We are subject to the requirements of the Sarbanes-Oxley Act and are obligated to obtain an audit opinion on the effectiveness of internal control over financial reporting. These internal controls may not be determined to be effective, and our business could be adversely impacted if there are deficiencies in our disclosure controls and procedures or internal control over financial reporting.
- We may have assumed unknown liabilities in connection with our acquisitions which could result in unexpected liabilities and expenses.
- Required payments of principal and interest on our Credit Facility may leave us with insufficient cash to operate our properties or to pay the distributions currently contemplated or necessary to qualify as a REIT and may expose us to the risk of default under our debt obligations.
- We could become highly leveraged in the future because our organizational documents contain no limitations on the amount of debt that we may incur.
- Increases in interest rates may increase our interest expense and adversely affect our cash flows and our ability to service our indebtedness and to make distributions to our shareholders.
- The Company may enter into swap agreements from time to time that may not effectively reduce its exposure to changes in interest rates.
- Our use of OP units in our operating partnership as currency to acquire properties could result in stockholder dilution and/or limit our ability to sell such properties, which could have a material adverse effect on us.
- Our charter restricts the ownership and transfer of our outstanding shares which may have the effect of delaying, deferring or preventing a transaction or change of control of our Company.
- Certain provisions of Maryland law could inhibit changes of control, which may discourage third parties from conducting a tender offer or seeking other change of control transactions that could involve a premium price for our common stock or that our stockholders otherwise believe to be in their best interests.
- We could increase the number of authorized shares, classify and reclassify unissued shares and issue shares without stockholder approval.
- Certain provisions in the partnership agreement of our operating partnership may delay or prevent unsolicited acquisitions of us.
- We may change our business, investment and financing strategies without stockholder approval.
- Our rights and the rights of our stockholders to take action against our directors and officers are limited, which could limit your recourse in the event that we take certain actions which are not in your best interests.
- We are a holding company with no direct operations and, as such, we will rely on funds received from our subsidiaries to pay liabilities, and the interests of our stockholders will be structurally subordinated to all liabilities and obligations of our subsidiaries.
- Our operating partnership may issue additional OP units to third parties without the consent of our stockholders, which would reduce our ownership percentage in our operating partnership and would have a dilutive effect on the amount of distributions made to us by our operating partnership and, therefore, the amount of distributions we can make to our stockholders.
- Risks Related to Our Qualification and Operation as a REIT
- Failure to remain qualified as a REIT, would cause us to be taxed as a regular corporation, which would adversely affect the value of our shares and substantially reduce funds available for distributions to our stockholders.
- If our operating partnership failed to qualify as a “partnership” for U.S. federal income tax purposes, we would cease to qualify as a REIT and suffer other adverse consequences.
- We may face other tax liabilities that reduce our cash flows.
- To maintain our status as a REIT and avoid the payment of U.S. federal income and excise taxes, we may be forced to borrow funds, use proceeds from the issuance of securities, pay taxable dividends of our stock or debt securities or sell assets to make distributions, in each case during unfavorable market conditions and which may result in our distributing amounts that would otherwise be used for our operations.
- Complying with the REIT requirements may cause us to forego otherwise attractive opportunities or liquidate otherwise attractive investments.
- The “prohibited transactions” tax may limit our ability to dispose of our properties.
- Any ownership of a TRS will be subject to limitations, and our transactions with a TRS cause us to be subject to a 100% penalty tax on certain income or deductions if those transactions are not conducted on arm’s-length terms.
- TRSs will be subject to federal and state income taxes.
- If a TRS tenant failed to qualify as a TRS, or the operator of a facility engaged by a TRS tenant did not qualify as an “eligible independent contractor,” we could fail to qualify as a REIT and could be subject to higher taxes and have less cash available for distribution to our stockholders.
- If leases of our properties are not respected as true leases for U.S. federal income tax purposes, we would fail to qualify as a REIT and would be subject to higher taxes and have less cash available for distribution to our stockholders.
- You may be restricted from acquiring or transferring certain amounts of our common stock.
Legal proceedings
The Company may, from time to time, be involved in litigation arising in the ordinary course of business or which may be expected to be covered by insurance. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGARDavid H. Dupuy, President
- 17
- 18
- 19
- 20
- 21
- 22SEC EDGARCathrine Cotman, Board member
- 23SEC EDGARClaire M. Gulmi, Board member
- 24SEC EDGARAlan Gardner, Board member
- 25SEC EDGARAlfred Lumsdaine, Board member
- 26SEC EDGARRobert Z. Hensley, Board member
- 27
- 28SEC EDGARShareholder vote
- 29
- 30
- 31SEC EDGARExecutive or director change
- 32SEC EDGARRegulation FD disclosure
- 33
- 34
- 35
- 36SEC EDGARShareholder vote
- 37
- 38
- 39NasdaqNasdaq calendar
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47